An experimental cocktail of three drugs can dramatically shorten the time it takes to treat patients infected with tuberculosis (TB) strains that are hard to cure with conventional antibiotics, ...
A novel drug combination (PaMZ) designed to treat both drug-sensitive and MDR-TB, including those who are HIV positive, is advancing to the crucial Phase III human clinical trial. If all goes well, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results